메뉴 건너뛰기




Volumn 35, Issue 2, 2015, Pages 230-234

Efficacy of telbivudine in the treatment of chronic hepatitis b and liver cirrhosis and its effect on immunological responses

Author keywords

Chronic hepatitis B; Interferon ; Interleukin 10; Liver cirrhosis; Telbivudine

Indexed keywords

ANTIVIRUS AGENT; TELBIVUDINE; THYMIDINE;

EID: 84928340724     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-015-1416-3     Document Type: Article
Times cited : (10)

References (39)
  • 1
    • 1642410856 scopus 로고    scopus 로고
    • Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
    • COI: 1:STN:280:DC%2BD2c7gs1Whug%3D%3D, PID: 14996343
    • Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat, 2004,11(2):97–107
    • (2004) J Viral Hepat , vol.11 , Issue.2 , pp. 97-107
    • Lavanchy, D.1
  • 2
    • 79960699693 scopus 로고    scopus 로고
    • Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size
    • PID: 21617533
    • Luo Z, Xie Y, Deng M, et al. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size. Eur J Gastroenterol Hepatol, 2011,23(8):695–700
    • (2011) Eur J Gastroenterol Hepatol , vol.23 , Issue.8 , pp. 695-700
    • Luo, Z.1    Xie, Y.2    Deng, M.3
  • 3
    • 84862942769 scopus 로고    scopus 로고
    • Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures
    • PID: 22041528
    • Tanaka M, Katayama F, Kato H, et al. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol, 2011,21(6):401–416
    • (2011) J Epidemiol , vol.21 , Issue.6 , pp. 401-416
    • Tanaka, M.1    Katayama, F.2    Kato, H.3
  • 4
    • 24344435917 scopus 로고    scopus 로고
    • Epidemiology and natural history of hepatitis B
    • PID: 16103976
    • McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis, 2005,25(Suppl 1):3–8
    • (2005) Semin Liver Dis , vol.25 , pp. 3-8
    • McMahon, B.J.1
  • 5
    • 84862915577 scopus 로고    scopus 로고
    • Effect and predictive elements for 52 weeks’ telbivudine treatment on naive HBeAg positive chronic hepatitis B
    • PID: 22368682
    • Zhu XF, Lu LX, Wang Y, et al. Effect and predictive elements for 52 weeks’ telbivudine treatment on naive HBeAg positive chronic hepatitis B. Hepat Mon, 2011,11(12):980–985
    • (2011) Hepat Mon , vol.11 , Issue.12 , pp. 980-985
    • Zhu, X.F.1    Lu, L.X.2    Wang, Y.3
  • 6
    • 84882877800 scopus 로고    scopus 로고
    • Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha
    • COI: 1:CAS:528:DC%2BC3sXhtFKltL7P, PID: 23890815
    • Pollicino T, Bellinghieri L, Restuccia A, et al. Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. Virology. 2013,444(1–2):317–328
    • (2013) Virology , vol.444 , Issue.1-2 , pp. 317-328
    • Pollicino, T.1    Bellinghieri, L.2    Restuccia, A.3
  • 7
    • 0035189597 scopus 로고    scopus 로고
    • Chronic hepatitis B
    • COI: 1:STN:280:DC%2BD3MnosV2qtw%3D%3D, PID: 11732013
    • Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology, 2001,34(6):1225–1241
    • (2001) Hepatology , vol.34 , Issue.6 , pp. 1225-1241
    • Lok, A.S.1    McMahon, B.J.2
  • 8
    • 0036461318 scopus 로고    scopus 로고
    • Immunology of hepatitis B infection
    • COI: 1:CAS:528:DC%2BD38Xht1Oltbo%3D, PID: 11892495
    • Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis, 2002,2(1):43–50
    • (2002) Lancet Infect Dis , vol.2 , Issue.1 , pp. 43-50
    • Jung, M.C.1    Pape, G.R.2
  • 9
    • 0036293243 scopus 로고    scopus 로고
    • Global control of hepatitis B virus infection
    • PID: 12127351
    • Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis, 2002,2(7):395–403
    • (2002) Lancet Infect Dis , vol.2 , Issue.7 , pp. 395-403
    • Kao, J.H.1    Chen, D.S.2
  • 10
    • 4644308995 scopus 로고    scopus 로고
    • Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity
    • Kondo Y, Asabe S, Kobayashi K, et al. Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity. J Med Virol, 2004,4(3):425–433
    • (2004) J Med Virol , vol.4 , Issue.3 , pp. 425-433
    • Kondo, Y.1    Asabe, S.2    Kobayashi, K.3
  • 11
    • 70350026318 scopus 로고    scopus 로고
    • HBX-mediated migration of HBV-replicating HepG2 cells: insights on development of hepatocellular carcinoma
    • PID: 19763277
    • Feng H, Zhang J, Li X, et al. HBX-mediated migration of HBV-replicating HepG2 cells: insights on development of hepatocellular carcinoma. J Biomed Biotechnol, 2009, 2009: 930268
    • (2009) J Biomed Biotechnol , vol.2009 , pp. 930268
    • Feng, H.1    Zhang, J.2    Li, X.3
  • 12
    • 79953315167 scopus 로고    scopus 로고
    • Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B
    • COI: 1:CAS:528:DC%2BC3MXmslymu7g%3D, PID: 21457439
    • Gane EJ, Wang Y, Liaw YF, et al. Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B. Liver Int, 2011,31(5):676–684
    • (2011) Liver Int , vol.31 , Issue.5 , pp. 676-684
    • Gane, E.J.1    Wang, Y.2    Liaw, Y.F.3
  • 13
    • 37349120537 scopus 로고    scopus 로고
    • Telbivudine versus lamivudine in patients with chronic hepatitis B
    • COI: 1:CAS:528:DC%2BD2sXhsVKht7nF, PID: 18094378
    • Lai CL, Gane E, Liaw YF, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med, 2007,20;357(25):2576–2588
    • (2007) N Engl J Med , vol.357 , Issue.25 , pp. 2576-2588
    • Lai, C.L.1    Gane, E.2    Liaw, Y.F.3
  • 14
    • 61849132825 scopus 로고    scopus 로고
    • On-treatment outcome prediction and adjustment during chronic hepatitis B therapy: now and future
    • COI: 1:CAS:528:DC%2BD1MXktVertbc%3D, PID: 19320233
    • Liaw YF. On-treatment outcome prediction and adjustment during chronic hepatitis B therapy: now and future. Antivir Ther, 2009,14(1):13–22
    • (2009) Antivir Ther , vol.14 , Issue.1 , pp. 13-22
    • Liaw, Y.F.1
  • 15
    • 0041760773 scopus 로고    scopus 로고
    • Assessment of prognosis in alcoholic liver disease: can serum hyaluronate replace liver biopsy?
    • PID: 12923364
    • Phillips MG, Preedy VR, Hughes RD. Assessment of prognosis in alcoholic liver disease: can serum hyaluronate replace liver biopsy? Eur J Gastroenterol Hepatol, 2003,15(9):941–944
    • (2003) Eur J Gastroenterol Hepatol , vol.15 , Issue.9 , pp. 941-944
    • Phillips, M.G.1    Preedy, V.R.2    Hughes, R.D.3
  • 16
    • 0033849619 scopus 로고    scopus 로고
    • Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF)
    • COI: 1:STN:280:DC%2BD3cvislylsg%3D%3D, PID: 10960438
    • Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology, 2000,32(3):477–481
    • (2000) Hepatology , vol.32 , Issue.3 , pp. 477-481
    • Cadranel, J.F.1    Rufat, P.2    Degos, F.3
  • 17
    • 0022656928 scopus 로고
    • Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver
    • COI: 1:STN:280:DyaL287ksFynsw%3D%3D, PID: 2869260
    • Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet, 1986,1(8480):523–525
    • (1986) Lancet , vol.1 , Issue.8480 , pp. 523-525
    • Maharaj, B.1    Maharaj, R.J.2    Leary, W.P.3
  • 18
    • 0020052042 scopus 로고
    • Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision techniques—a review
    • COI: 1:STN:280:DyaL383htFKluw%3D%3D, PID: 6211383
    • Nord HJ. Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision techniques—a review. Gastrointest Endosc, 1982,28(2):102–104
    • (1982) Gastrointest Endosc , vol.28 , Issue.2 , pp. 102-104
    • Nord, H.J.1
  • 19
    • 0022647490 scopus 로고
    • Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies
    • COI: 1:STN:280:DyaL287mvFGgsw%3D%3D, PID: 3958472
    • Piccinino F, Sagnelli E, Pasquale G, et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol, 1986,2(2):165–173
    • (1986) J Hepatol , vol.2 , Issue.2 , pp. 165-173
    • Piccinino, F.1    Sagnelli, E.2    Pasquale, G.3
  • 20
    • 0036793878 scopus 로고    scopus 로고
    • Prothrombin index decrease: a useful and reliable marker of extensive fibrosis?
    • COI: 1:CAS:528:DC%2BD38XnsVKrtLc%3D, PID: 12362094
    • Cadranel JF, Mathurin P. Prothrombin index decrease: a useful and reliable marker of extensive fibrosis? Eur J Gastroenterol Hepatol, 2002,14(10):1057–1059
    • (2002) Eur J Gastroenterol Hepatol , vol.14 , Issue.10 , pp. 1057-1059
    • Cadranel, J.F.1    Mathurin, P.2
  • 21
    • 0036793935 scopus 로고    scopus 로고
    • Prothrombin index is an indirect marker of severe liver fibrosis
    • COI: 1:CAS:528:DC%2BD38XnsVKrtbs%3D, PID: 12362105
    • Croquet V, Vuillemin E, Ternisien C, et al. Prothrombin index is an indirect marker of severe liver fibrosis. Eur J Gastroenterol Hepatol, 2002,14(10):1133–1141
    • (2002) Eur J Gastroenterol Hepatol , vol.14 , Issue.10 , pp. 1133-1141
    • Croquet, V.1    Vuillemin, E.2    Ternisien, C.3
  • 22
    • 0030830281 scopus 로고    scopus 로고
    • Noninvasive diagnosis of hepatic fibrosis or cirrhosis
    • COI: 1:CAS:528:DyaK2sXnt1Oqu7k%3D, PID: 9352863
    • Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology, 1997,113(5):1609–1616
    • (1997) Gastroenterology , vol.113 , Issue.5 , pp. 1609-1616
    • Oberti, F.1    Valsesia, E.2    Pilette, C.3
  • 23
    • 0033782827 scopus 로고    scopus 로고
    • Serum hyaluronan—a non-invasive test for diagnosing liver cirrhosis
    • COI: 1:CAS:528:DC%2BD3cXnvV2ltb0%3D, PID: 11057458
    • Plevris JN, Haydon GH, Simpson KJ, et al. Serum hyaluronan—a non-invasive test for diagnosing liver cirrhosis. Eur J Gastroenterol Hepatol, 2000,12(10):1121–1127
    • (2000) Eur J Gastroenterol Hepatol , vol.12 , Issue.10 , pp. 1121-1127
    • Plevris, J.N.1    Haydon, G.H.2    Simpson, K.J.3
  • 24
    • 0028256364 scopus 로고
    • Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C
    • COI: 1:CAS:528:DyaK2cXktVKntLY%3D, PID: 8014451
    • Guechot J, Poupon RE, Giral P, et al. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol, 1994,20(3):388–393
    • (1994) J Hepatol , vol.20 , Issue.3 , pp. 388-393
    • Guechot, J.1    Poupon, R.E.2    Giral, P.3
  • 25
    • 84887018337 scopus 로고    scopus 로고
    • The regulation of inflammation by interferons and their STATs
    • PID: 24058799
    • Rauch I, Muller M, Decker T. The regulation of inflammation by interferons and their STATs. JAKSTAT, 2013,2(1):e23820
    • (2013) JAKSTAT , vol.2 , Issue.1 , pp. e23820
    • Rauch, I.1    Muller, M.2    Decker, T.3
  • 26
    • 68049142973 scopus 로고    scopus 로고
    • Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C
    • COI: 1:CAS:528:DC%2BD1MXpsFyhsrk%3D, PID: 19596474
    • Bonorino P, Ramzan M, Camous X, et al. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J Hepatol, 2009,51(3):458–467
    • (2009) J Hepatol , vol.51 , Issue.3 , pp. 458-467
    • Bonorino, P.1    Ramzan, M.2    Camous, X.3
  • 27
    • 33947411395 scopus 로고    scopus 로고
    • Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage
    • COI: 1:CAS:528:DC%2BD2sXjsVyqsrY%3D, PID: 17353365
    • Dunn C, Brunetto M, Reynolds G, et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med, 2007,204(3):667–680
    • (2007) J Exp Med , vol.204 , Issue.3 , pp. 667-680
    • Dunn, C.1    Brunetto, M.2    Reynolds, G.3
  • 28
    • 69249113887 scopus 로고    scopus 로고
    • Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections
    • COI: 1:CAS:528:DC%2BD1MXhtF2is7%2FO, PID: 19470388
    • Oliviero B, Varchetta S, Paudice E, et al. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology, 2009,137(3):1151–1160, 60 e1-e7
    • (2009) Gastroenterology , vol.137 , Issue.3 , pp. 1151-1160
    • Oliviero, B.1    Varchetta, S.2    Paudice, E.3
  • 29
    • 78751482977 scopus 로고    scopus 로고
    • Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients
    • COI: 1:CAS:528:DC%2BC3MXitVeksrY%3D, PID: 21254163
    • Zhang Z, Zhang S, Zou Z, et al. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology, 2011,53(1):73–85
    • (2011) Hepatology , vol.53 , Issue.1 , pp. 73-85
    • Zhang, Z.1    Zhang, S.2    Zou, Z.3
  • 30
    • 79251563757 scopus 로고    scopus 로고
    • Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil
    • PID: 21127728
    • Jiang Y, Ma Z, Xin G, et al. Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil. Mediators Inflamm, 2010,2010: 143026
    • (2010) Mediators Inflamm , vol.2010 , pp. 143026
    • Jiang, Y.1    Ma, Z.2    Xin, G.3
  • 31
    • 36549070632 scopus 로고    scopus 로고
    • Therapy of chronic hepatitis B: focus on telbivudine
    • COI: 1:CAS:528:DC%2BD1cXhvF2qt70%3D, PID: 18063258
    • Gaeta GB, Stornaiuolo G. Therapy of chronic hepatitis B: focus on telbivudine. Dig Liver Dis, 2007,39(Suppl 3):S372–S378
    • (2007) Dig Liver Dis , vol.39 , pp. S372-S378
    • Gaeta, G.B.1    Stornaiuolo, G.2
  • 32
    • 77952576643 scopus 로고    scopus 로고
    • Innate and adaptive immune responses in hepatitis B virus infection
    • PID: 20460900
    • Das A, Maini MK. Innate and adaptive immune responses in hepatitis B virus infection. Dig Dis, 2010,28(1):126–132
    • (2010) Dig Dis , vol.28 , Issue.1 , pp. 126-132
    • Das, A.1    Maini, M.K.2
  • 33
    • 84861078273 scopus 로고    scopus 로고
    • Effects of telbivudine treatment on the circulating CD4(+) T-cell subpopulations in chronic hepatitis B patients
    • PID: 22570512
    • Zheng Y, Huang Z, Chen X, et al. Effects of telbivudine treatment on the circulating CD4(+) T-cell subpopulations in chronic hepatitis B patients. Mediators Inflamm, 2012,2012:789859
    • (2012) Mediators Inflamm , vol.2012 , pp. 789859
    • Zheng, Y.1    Huang, Z.2    Chen, X.3
  • 34
    • 84861483182 scopus 로고    scopus 로고
    • Effects of antiviral therapy with telbivudine on peripheral iNKT cells in HBeAg(+) chronic hepatitis B patients
    • COI: 1:CAS:528:DC%2BC38XmtlCqsr4%3D, PID: 21748522
    • Shi TD, Zhang JM, Wang XF, et al. Effects of antiviral therapy with telbivudine on peripheral iNKT cells in HBeAg(+) chronic hepatitis B patients. Clin Exp Med, 2012,12(2):105–113
    • (2012) Clin Exp Med , vol.12 , Issue.2 , pp. 105-113
    • Shi, T.D.1    Zhang, J.M.2    Wang, X.F.3
  • 35
    • 84868324382 scopus 로고    scopus 로고
    • Natural killer cells are characterized by the concomitantly increased interferon-gamma and cytotoxicity in acute resolved hepatitis B patients
    • COI: 1:CAS:528:DC%2BC38XhslWjsb%2FK, PID: 23133672
    • Zhao J, Li Y, Jin L, et al. Natural killer cells are characterized by the concomitantly increased interferon-gamma and cytotoxicity in acute resolved hepatitis B patients. PLoS One, 2012,7(11):e49135
    • (2012) PLoS One , vol.7 , Issue.11 , pp. e49135
    • Zhao, J.1    Li, Y.2    Jin, L.3
  • 36
    • 61449152973 scopus 로고    scopus 로고
    • Regulatory T cells and viral liver disease
    • PID: 19222744
    • Alatrakchi N, Koziel M. Regulatory T cells and viral liver disease. J Viral Hepat, 2009,16(4):223–229
    • (2009) J Viral Hepat , vol.16 , Issue.4 , pp. 223-229
    • Alatrakchi, N.1    Koziel, M.2
  • 37
    • 1642453559 scopus 로고    scopus 로고
    • Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells
    • PID: 14726762
    • Cottrez F, Groux H. Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells. Transplantation, 2004,77(1 Suppl):S12–S15
    • (2004) Transplantation , vol.77 , Issue.1 , pp. S12-S15
    • Cottrez, F.1    Groux, H.2
  • 38
    • 16244385911 scopus 로고    scopus 로고
    • Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection
    • COI: 1:CAS:528:DC%2BD2MXjsV2msLs%3D, PID: 15791617
    • Stoop JN, van der Molen RG, Baan CC, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology, 2005,41(4):771–778
    • (2005) Hepatology , vol.41 , Issue.4 , pp. 771-778
    • Stoop, J.N.1    van der Molen, R.G.2    Baan, C.C.3
  • 39
    • 84863011093 scopus 로고    scopus 로고
    • Inhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B
    • COI: 1:CAS:528:DC%2BC38Xhsl2jurs%3D, PID: 22233255
    • Nan XP, Zhang Y, Yu HT, et al. Inhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B. Viral Immunol, 2012,25(1):21–8
    • (2012) Viral Immunol , vol.25 , Issue.1 , pp. 21-28
    • Nan, X.P.1    Zhang, Y.2    Yu, H.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.